Aspen Aerogels, Inc. Reports Third Quarter 2025 Financial Results and Recent Business Highlights
1. Q3 2025 revenue fell to $73 million from $117 million year-over-year. 2. Net loss improved to $6.3 million, down from $13 million in Q3 2024. 3. Adjusted EBITDA of $6.3 million, decreased significantly from $25.4 million YoY. 4. Aspen anticipates stabilization in EV markets and growth in Energy Industrial sector. 5. Awarded major contract for PyroThin® to begin production in 2027.